baber/WOPTO huggingface dataset:
Patent NZ-542951-A (NZ)
Title: Azabicyclo derivatives as muscarinic receptor antagonists
Inventor: KUMAR NARESH
IPC: A61P1/00
Filed: 2004-01-07
Abstract: The disclosure relates to muscarinic receptor antagonists which are azabicyclo derivatives such as (2R, 2S)(1alpha, 5alpha, 6alpha)-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The disclosure also relates to pharmaceutical compositions containing these compounds and their use for treating the diseases mediated through muscarinic receptors.
Patent NZ-543514-A (NZ)
Title: Fiberoptic faraday effect sensor
Inventor: BJORN LARS NORGAARD
IPC: G01R35/00
Filed: 2004-05-12
Abstract: An electric current measurement device is disclosed. The device comprises a housing defining a first open end and a second open end opposite to the first open end. A first sealing means has an aperture and has an overall geometrical configuration corresponding to the overall geometrical configuration of the first open end of the housing. The first sealing means further comprises an aperture adapted for receiving a first optical fibre to be fixated by means of a first fixture means. A first optical lens has a reception part for receiving the first fixture means for mounting the first optical fibre in optical continuation with the first optical lens. A first polarisation filter mounted in the housing in optical continuation with the first optical lens. A glass rod is received in and encapsulated within the housing in optical continuation with the first polarisation filter. The glass rod is constructed from a material having magneto-optical properties. The device further comprises a second polarisation filter mounted in the housing in optical continuation with the glass rod, a second optical lens mounted in the housing, a second fixture means for fixating a second optical fibre, and a second sealing means for sealing the second end of the housing. The device further comprises a first and second lid adapted for fixation to the first and second end of the housing. The first and second lids include an aperture for receiving the first and second optical fibres.
Patent NZ-550833-A (NZ)
Title: Bottom basket lifting arrangement for a dishwasher
Inventor: DELLBY FREDRIK
IPC: A47L/
Filed: 2005-04-07
Abstract: A dishwasher has a wash cabinet 10 having a bottom, two opposite side walls 11, an upper and a rear wall and an opening that normally is covered by a front door 12. The dishwasher is provided with at least one lower basket 13 for the dishes being cleaned, the basket being movable between a first position inside the cabinet and a second position mainly outside the cabinet. Each side of the opening has a support 21 arranged to move mainly vertically in or close to the side walls 11 for raising the lower basket 13 from a lower to an upper position and vice versa. The supports 21 are attached to a respective block 18 which slides up and down in a channel 17 as wire 19 is wound in or out. As the blocks 18 move up from the bottom of the channels 17 the supports 21 are arranged to rotate from an inactive position out of engagement with the lower basket 13 to an active position in which they are in engagement with the lower basket.
Patent NZ-553892-A (NZ)
Title: Pyrrolizidine or loline alkaloid based pesticidal composition
Inventor: PENNELL CHRISTOPHER GERALD LEE
Filed: 2007-03-15
Abstract: Disclosed is a pesticidal composition obtained from an aqueous extraction of a plant and endophyte combination, wherein the aqueous extract contains at least one pyrrolizidine alkaloid compound, wherein the pyrrolizidine compound is of Formula [I], wherein R is H or CH3 and R' is H, CH3, CHO or COCH3. A plant not infected with an endophyte can be protected from pests by application of the above composition.
Patent NZ-561138-A (NZ)
Title: Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer
Inventor: GOMEZ-NAVARRO JESUS
Filed: 2006-03-03
Abstract: Disclosed is the use of a therapeutically effective amount of an anti CTLA4 antibody or an antigen-binding portion thereof, in combination with a therapeutically effective amount of an indolinone receptor tyrosine kinase inhibitor (RTKI) for the manufacture of a medicament for the treatment of cancer.
Patent NZ-562729-A (NZ)
Title: Novel method for preventing or treating M tuberculosis infection using Mtb72f fusion proteins
Inventor: COLER RHEA
IPC: A61K39/04
Filed: 2006-04-27
Abstract: Disclosed is the use of a Mtb72f fusion protein comprising: (i) residues 8-729 of the sequence of SEQ ID No: 2 or a variant thereof having at least 90% identity thereto; or (ii) residues 4-725 of the sequence of SEQ ID No: 4 or a variant thereof having at least 90% identity thereto; and an adjuvant, wherein the Mtb72f fusion protein induces an immune response against M tuberculosis, in the manufacture of a pharmaceutical composition for preventing or treating tuberculosis reactivation in a mammal already infected with Mycobacterium tuberculosis.
Patent NZ-564159-A (NZ)
Title: Power tong device
Inventor: VATNE PER A
IPC: E21B/
Filed: 2006-06-09
Abstract: Mechanised pipe tongs in the form of a power tong (1) device is disclosed. The power tong includes two housing halves (2) arranged to be pivoted between a closed, active position and an open, inactive position. A radially divided drive ring (6, 8) provided with hydraulically activated clamping dies (14) directed towards the centre axis of the power tong is placed in the housing halves. The drive ring is supported and connected to a driving motor (12) for the rotation of the drive ring about the centre axis. The drive ring is provided with at least one locking means which is arranged to interconnect the parts of the drive ring (6, 8) in a releasable manner.
Patent NZ-571110-A (NZ)
Title: Methods of using GPR119 receptor to identify Glucose-dependent Insulinotropic Peptide (GIP) secretagogue compounds useful for increasing bone mass in an individual
Inventor: CHU ZHI-LIANG
IPC: G01N33/50
Filed: 2007-04-10
Abstract: Methods for identifying a Glucose-dependent Insulinotropoic Peptide (GIP) secretagogue using the G-protein coupled receptor GPR119 receptor. GIP secretagogues are useful as therapeutic agents for treating or preventing a condition characterised by low bone mass, such as osteoporosis, and for increasing bone mass in an individual.
Patent NZ-573564-A (NZ)
Title: PS4 variant polypeptide with amylase activity
Inventor: DERKX PATRICK MARIA FRANCISCUS
IPC: A23L7/104
Filed: 2007-06-19
Abstract: Disclosed is a variant polypeptide of a parent polypeptide having amylase activity, in which the variant polypeptide has amylase activity and has at least 70% identity to SEQ ID NO: 1, and comprises an amino acid substitution at position 307 to lysine (K) or arginine (R), with reference to the position numbering of a Pseudomonas saccharophilia exoamylase sequence shown as SEQ ID NO: 1. Also disclosed is the use of the said polypeptide as a food or feed additive.
Patent NZ-578042-A (NZ)
Title: Method for the synthesis of sucrose-6-esters
Inventor: BOUTZALE WAYNE N
IPC: C07H1/00
Filed: 2008-01-04
Abstract: Disclosed is a process for the synthesis of a sucrose-6-ester comprising: (a) forming a first reaction mixture comprising sucrose, a polar aprotic solvent, and an organotin-based acylation promoter; (b) removal of water from said first reaction mixture by contacting, in a continuous counter-current manner, with gas or solvent vapour capable of removing water at a temperature, pressure and residence time sufficient to afford a second reaction mixture which is substantially free from water; followed by (c) adding a carboxylic anhydride to said second reaction mixture to afford a third reaction mixture, and maintaining said third reaction mixture at a temperature and for a period of time sufficient to produce a sucrose-6-ester.
Patent NZ-579404-A (NZ)
Title: Multilayer structure formed by nanoparticular lamina with unidimensional photonic crystal properties, method for the production thereof and use thereof
Inventor: OCANA JURADO MANUEL
IPC: G02B1/02
Filed: 2008-02-20
Abstract: Disclosed is a mesoporous nanoparticulate multilayer structure, having pores whose average size is in the range comprised between 1 nm and 100nm, with the properties of a Bragg reflector or unidimensional photonic crystal, characterised in that it comprises periodically alternating laminae composed of nanoparticles, the laminae having different refractive indices and a thickness between 1 nm and 200 nm. Further disclosed is the a process for obtaining the nanoparticulate multilayer structure, characterised in that it comprises the following stages: a) preparation of suspensions of nanoparticles, the composition of which is that of any material that can be obtained in the form of a nanoparticle, where the suspension medium is any liquid wherein these particles can become dispersed, and where the concentration thereof is comprised between 1 percent and 99 percent by weight; and b) formation of a multilayer structure of a high interconnected porosity and with the properties of a unidimensional photonic crystal through the alternating deposition, on any substrate, of laminae of controlled thickness of nanoparticles based on the suspensions described in a), in such a manner as to create an alternation in refractive index value and wherein the thickness of each of the laminae of nanoparticles that forms the multilayer is comprised between 1 nm and 1 micron, and where the number of nanoparticulate laminae present in the multilayer may vary between 1 and 100 layers. Also disclosed is the use of said nanoparticulate multilayer structure in the manufacturing of optical elements.
Patent NZ-580259-A (NZ)
Title: Customized design applied from virtual to actual container
Inventor: SCHULTCHEN ARNE
IPC: B41F17/24
Filed: 2008-04-30
Abstract: An apparatus for providing a container (3) having at least one surface with a customized design, comprises: a memory containing at least one set of data comprising a plurality of design elements (320, 321, 322); a user interface comprising interface means and display means enabling the consumer to interact with the apparatus to allow the generation of a customized design of at least one surface of a virtual whitepack through selection and placement of at least one of the design elements and through visual representation of the selected at least one design element on the at least one surface of the virtual whitepack, an application unit for applying the customized design of the at least one surface of the virtual whitepack to at least one surface of a whitepack so as to obtain the container having the at least one surface with the customized design, and a logic control unit to which the memory, the user interface and the application unit are connected.
Patent NZ-587746-A (NZ)
Title: Automated shutter for dark acclimating samples having a head movable between an open and a closed position.
Inventor: RUNCIE JOHN W
IPC: G01N21/01
Filed: 2009-03-13
Abstract: An automated shutter for temporarily dark acclimating a sample in a bulk medium from ambient light, comprising a base (3) and a head (5) mounted to the base movable between an open and closed position. The automated shutter further comprises one or more artificial light sources (9) and one or more optical detectors (11) disposed in said head or base, and where the head (5) is adjacent or contiguous with the base when moved into the closed position. The sample is retained close to or contiguous with the head when in the closed position and is exposed to the bulk medium when in the open position.
Patent NZ-587793-A (NZ)
Title: Process for preparing bosentan
Inventor: GAITONDE ABHAY
IPC: C07D239/52
Filed: 2009-02-06
Abstract: Disclosed is a process for preparing bosentan comprising reacting a dichloro compound of formula (1) with a mono-protected ethylene glycol of formula HOCH2CH2OR, wherein R is a hydroxyl protecting moiety, to afford a compound of formula (2a): followed by introduction of a sulfonamide group. Also disclosed is the use of the bosentan prepared by the process for treating hypertension, ischemia, pulmonary hypertension, vasospasm and angina pectoris.
Patent NZ-590282-A (NZ)
Title: Directing a fluid to a teat using flow diverters on the inner surface of the milking cup
Inventor: TORGERSON KEVIN L
IPC: A01J7/04
Filed: 2009-06-25
Abstract: 590282 Disclosed is a milker unit liner dome for distributing teat dip before a milker unit is detached from an animal being milked. The liner dome comprises a barrel; and a dome joined to the barrel. The dome comprises an upper inner surface defining a teat opening; a flow diverter joined to the upper inner surface of the dome and the flow diverter includes a ridge extending away from the upper inner surface to at least partially define an open flow path along the upper inner surface and at least partially around the teat opening. An inlet slot with one way or non-return valve to the dome is disposed to direct fluid flow into contact with the flow diverter, and the flow diverter ridge is a bifurcating ridge or arcuate flow contact surface disposed adjacent or spaced apart to the inlet. The liner dome further comprises a second flow diverter comprising a ridge joined to the upper inner surface of the dome and the second flow diverter at least partially defines an open flow path along the upper inner surface of the dome and at least partially around the teat opening.
Patent NZ-592812-A (NZ)
Title: Fuel nozzle having a main valve that is closed in a tilted manner to reduce its tightness in a full hose mode
Inventor: MEYER HEINZ-ULRICH
IPC: B67D7/42
Filed: 2011-05-12
Abstract: 592812 Disclosed is a fuel pump nozzle, with an inlet (2), a discharge pipe (3), a main valve for controlling the stream of liquid between the inlet (2) and discharge pipe (3), a switching lever (4) for actuating the main valve, a first automatic safety shut-off which moves the main valve into the closed position if the liquid level in a tank to be filled reaches a filling level sensor arranged in the region of the discharge pipe (3), a second automatic safety shut-off which moves the main valve into the closed position if the liquid pressure at the inlet (2) drops below a minimum value, and a mechanism (13) for prestressing the main valve into the closed position, the mechanism bringing about a variable opening cross section of the main valve depending on the liquid pressure at the inlet (2). According to the invention, the main valve is pressed into the closed position in a tilted manner under the action of the mechanism for prestressing the main valve into the closed position in the full hose mode such that the tightness of the main valve is reduced.
Patent NZ-595101-A (NZ)
Title: Animal tag
Inventor: SMITH ALEX
IPC: A01K11/00
Filed: 2010-02-08
Abstract: 595101 Disclosed is an animal ear tag for identification of an animal. The tag comprises a body portion that can be folded about a central axis to close the tag. The central axis is defined by a living hinge. A closure element is provided to hold the tag in the closed position. The body portion comprises a first substantially planar member (8) extending from the living hinge in a first direction of elongation and a second substantially planar member (10) extending from the opposite side of the living hinge in a second direction of elongation. Curved sections join the substantially elongate members to the living hinge. When the ear tag is in the closed position the closure element is offset from a perpendicular axis of the central axis. The offset improves visibility of the jaws of an applicator when several tags are loaded into an applicator.
Patent NZ-596326-A (NZ)
Title: Novel solvate crystals
Inventor: KIYOTA HIROSHI
IPC: A61K31/4178
Filed: 2010-04-27
Abstract: 596326 Disclosed herein are acetone solvate crystalline forms of trityl olmesartan medoxomil. Additionally disclosed are methods for preparing the compounds comprising tritylation and DMDO esterification reactions followed by crystallisation of the acetone solvate crystals.
Patent NZ-599099-A (NZ)
Title: Phenyloxadiazole derivatives as pgds inhibitors
Inventor: WEIBERTH FRANZ J
IPC: A61K31/506
Filed: 2010-10-07
Abstract: This disclosure is directed to a compound of formula (I): wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).
Patent NZ-604237-A (NZ)
Title: Dilutable biocidal compositions and methods of use
Inventor: CALLAHAN MOLLY RYAN
IPC: A01N25/00
Filed: 2011-06-07
Abstract: Disclosed is a composition comprising: about 7.5% hydrogen peroxide by weight, about 6.4 % of a quaternary ammonium compound by weight, about 0.3 % amine oxide by weight; about 0.225% phosphoric acid by weight; and water, wherein the quaternary ammonium compound comprises n-alkyl dimethyl benzyl ammonium chloride, n-octyl decyl dimethyl ammonium chloride, di-n-octyl dimethyl ammonium chloride, and di-n-decyl dimethyl ammonium chloride. These compositions are dilutable biocidal composition, when diluted, they provide a microbial contact kill time of less than 5 minutes for at least one biocidal target selected from bacterium selected from the group consisting of Campylobacter jejuni, Pseudomonas aeruginosa, Salmonella enterica, Staphylococcus aureus, Streptococcus pyogenes, and Clostridium difficile, or a virus, or a combination thereof.
Patent NZ-621200-A (NZ)
Title: Beverages with enhanced flavors and aromas and method of making same
Inventor: DA CRUZ MARCIO J
IPC: A23F5/46
Filed: 2009-02-19
Abstract: Disclosed is a soluble coffee product, comprising: a dry coffee extract component; and a pulverized coffee component the pulverized coffee component having a mean particle size of about 350 microns or less; wherein the pulverized coffee component has not been extracted, and wherein the pulverized coffee component is added to the dry coffee extract component after the dry coffee extract component is dried, and wherein the soluble coffee product further comprises at least one selected from the group consisting of coffee extract, concentrated coffee, dried coffee, coffee oils, coffee aromas, distillates, flavor powders, flavor oils, spices, ground or pulverized cocoa beans, ground or pulverized vanilla beans, vitamins, antioxidants, nutraceuticals, dietary fiber, an omega-3 oil, an omega-6 oil, an omega-9 oil, a flavonoid, lycopene, selenium, a beta-carotene, resveratrol, a vegetable extract, a dry green coffee extract, a wet green coffee extract and an herbal extract.
Patent NZ-628207-A (NZ)
Title: Energy-rich liquid nutritional composition having improved organoleptic properties
Inventor: DE KORT ESTHER JACQUELINE PETRA
IPC: A23L33/00
Filed: 2013-02-28
Abstract: Liquid nutritional composition having a pH in a range of 6 to 8, comprising 6 to 20 g/100 ml protein, said protein comprising micellar casein, and wherein lactic acid is present in an amount up to 1.5 g/100 ml.
Patent NZ-630762-A (NZ)
Title: A respiratory pressure treatment system
Inventor: ROW NATHAN JOHN
IPC: A61M16/00
Filed: 2014-09-12
Abstract: An apparatus for use in treating a respiratory disorder comprising: a housing (including e.g. side panel 4014); a pressure generator within the housing and configured to supply a flow of air; a device outlet fluidly coupled to the pressure generator and configured to be coupled to an air circuit to deliver the flow of air to a patient interface for treating a respiratory disorder; and a wireless data communication interface (4280) integrated within the housing, the wireless data communication interface configured to connect to another device or a network.
Patent NZ-703546-A (NZ)
Title: Composition comprising a mixture of cd95-fc isoforms
Inventor: HILL OLIVER
IPC: C12N15/62
Filed: 2013-07-18
Abstract: The present invention relates to a composition comprising a mixture of fusion protein isoforms, each fusion protein comprising an extracellular CD95 domain or a functional fragment thereof or an Fc domain or functional fragment thereof, formulations providing such composition in a stable form as well as a method for producing such a composition.
Patent NZ-707033-A (NZ)
Title: Dispersible nimorazole tablet
Inventor: TANHAJI DUMBRE NILESH
IPC: A61K31/5377
Filed: 2013-11-18
Abstract: The present invention relates to a tablet comprising Nimorazole. In particular, the invention concerns a pharmaceutical composition or a tablet comprising Nimorazole or a pharmaceutically acceptable salt thereof, for dispersion in water and administration via a tube to a patient with swallowing difficulties.
Patent NZ-710345-A (NZ)
Title: Golf club
Inventor: CORDLE ROBERT WILLIAM JOHN
IPC: A63B69/36
Filed: 2014-01-23
Abstract: In the game of golf, the conventional address position in which the player sets the head of the golf club behind the ball ready to play, is not the same as the optimum impact position when impacting with and hitting the ball during play. The present invention provides a golf club which facilitates the minimisation of the difference between these positions, to facilitate the reaching of an optimum impact position upon swinging. Accordingly, the disclosed golf club comprises an elongated shaft having a grip at a first longitudinal end thereof; a club head coupled to a second longitudinal end of the elongate shaft, the club head comprising a sole and a ball striking face. The sole is oriented relative to the shaft, where with the shaft in a vertical plane address position, the sole is positioned at an angle with respect to a horizontal line perpendicular to the vertical plane address position. The golf club further has an elongate marker comprising a longitudinal axis oriented such that, when sole of the golf club lies substantially parallel to a first plane of the ground, the longitudinal axis of the elongate marker extends in a second plane defined by a first vector in a direction substantially parallel to a normal of the face of the club head. The elongate marker is located at least partially on the connection portion and located on an uppermost surface of the club head so that the elongate marker appears to a user as a straight line parallel to the first plane of the ground when the golf club shaft is inclined forward from the first vector within said second plane. The longitudinal axis of the elongate marker is arranged to extend in a direction substantially parallel to the first vector when the angle of the forwardly-inclined golf club shaft is within said plane and such that the angle of the forwardly-inclined golf club shaft relative to the first vector is between approximately 3 degrees and approximately 30 degrees.